action of glp-1 agonist receptor agonists show promise in treating substance use disorders Recent updates on GLP-1 agonists:
Description
Use of DPP4 inhibitors and GLP-1 receptor agonists and risk of intestinal obstruction: scandinavian cohort study
The researchers concluded that berberine might be a good choice for patients with NAFLD and glucose metabolic disorders
Heterogeneity of hormone expression
Additionally, GLP-1 (50 nM) protected against synaptic dysfunction in the rat hippocampus induced by injection of lipopolysaccharide (LPS) (McClean et al., 2011)
